FDA clears drug for rare and deadly GI cancer developed by Canadian firm Zymeworks
Co-founder of Zymeworks calls approval “the dream that many said was not possible.”
Co-founder of Zymeworks calls approval “the dream that many said was not possible.”
Toronto Western Hospital is the exclusive Canadian surgical site for the experimental brain implant.
Six years in the making, UW’s startup incubator has a new home in the Innovation Arena.
The founder of exited startup Medesync wants to accelerate clinical research with AI.
Managing partner attributes success in a tough environment to its returns, committed anchor, and consistency.
The young Canadian founder accepted the award on the same stage as Shaquille O’Neal.
Lightspeed beats revenue forecasts as Well Health reaches record revenues in fiscal Q3 2024.
New integration is expected to let community pharmacies across North America outsource medication delivery.
This year’s winners achieved an average three-year revenue growth of 3,559 percent.
Jane App co-founder says she doesn’t understand recent calls for businesses to leave Canada.
AbCellera wants to be BC’s life sciences anchor company. It almost didn’t happen.
Investissement Québec and Fonds FTQ supported Epitopea’s pre-Series A round.
EnvisAGE dispensed $5 million to 16 projects while CABHI opened applications for a new accelerator program.
Jane App sported a 378 percent three-year revenue growth rate on last year’s Technology Fast 50.
After buying 18 million shares, Solina Chau now holds a 14 percent stake in Well.